| Connie Lynn Whitaker, APRN, FNP-C | |
|
808 Wall St, Norman, OK 73069-6302 | |
| (405) 997-4321 | |
| Not Available |
| Full Name | Connie Lynn Whitaker |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 808 Wall St, Norman, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083238612 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 92179 (Oklahoma) | Primary |
| Entity Name | Oklahoma Arthritis Center, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528036019 PECOS PAC ID: 0446239743 Enrollment ID: O20040720000063 |
News Archive
Researchers at the University of Texas Southwestern Medical Center and University of Chicago have discovered that bacteria that usually live in the gut can accumulate in tumors and improve the effectiveness of immunotherapy in mice.
A recent study by Jasmohan Bajaj, M.D., and colleagues from Virginia Commonwealth University and McGuire VA Medical Center found that patients with cirrhosis of the liver who developed minimal hepatic encephalopathy (MHE) had a 16% rate of motor vehicle crashes compared to only 4% of those without MHE over one year.
New research presented at the American Society of Clinical Oncology 53rd Annual Meeting in Chicago shows that a previously untested combination of a monoclonal antibody-drug conjugate with a common chemotherapy agent has a high complete-response rate in children and young adults with relapsed or refractory Hodgkin lymphoma.
A symposium to be hosted by the Johns Hopkins Brain Science Institute (BSi) on Oct. 18 at the Baltimore Convention Center will bring together the pharmaceutical industry and academic-based research institutions with the common goal of exploring how the two can best work together to enhance and facilitate the discovery of new drugs.
The COPD Foundation announces the launch of an unprecedented collaborative effort to pool information on Chronic Obstructive Pulmonary Disease (COPD): the COPD Biomarkers Qualification Consortium (CBQC). The CBQC brings together government agencies, academic institutions and pharmaceutical companies that will share research data on COPD biomarkers—indicators of disease progression/severity.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Connie Lynn Whitaker, APRN, FNP-C 808 Wall St, Norman, OK 73069-6302 Ph: (405) 977-4321 | Connie Lynn Whitaker, APRN, FNP-C 808 Wall St, Norman, OK 73069-6302 Ph: (405) 997-4321 |
News Archive
Researchers at the University of Texas Southwestern Medical Center and University of Chicago have discovered that bacteria that usually live in the gut can accumulate in tumors and improve the effectiveness of immunotherapy in mice.
A recent study by Jasmohan Bajaj, M.D., and colleagues from Virginia Commonwealth University and McGuire VA Medical Center found that patients with cirrhosis of the liver who developed minimal hepatic encephalopathy (MHE) had a 16% rate of motor vehicle crashes compared to only 4% of those without MHE over one year.
New research presented at the American Society of Clinical Oncology 53rd Annual Meeting in Chicago shows that a previously untested combination of a monoclonal antibody-drug conjugate with a common chemotherapy agent has a high complete-response rate in children and young adults with relapsed or refractory Hodgkin lymphoma.
A symposium to be hosted by the Johns Hopkins Brain Science Institute (BSi) on Oct. 18 at the Baltimore Convention Center will bring together the pharmaceutical industry and academic-based research institutions with the common goal of exploring how the two can best work together to enhance and facilitate the discovery of new drugs.
The COPD Foundation announces the launch of an unprecedented collaborative effort to pool information on Chronic Obstructive Pulmonary Disease (COPD): the COPD Biomarkers Qualification Consortium (CBQC). The CBQC brings together government agencies, academic institutions and pharmaceutical companies that will share research data on COPD biomarkers—indicators of disease progression/severity.
› Verified 8 days ago
Ms. Heidi Gehret Logsdon, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 900 N Porter Ave Ste 100, Norman, OK 73071 Phone: 405-914-4850 | |
Jodi M Dodson, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1139 36th Ave Nw, Suite 100, Norman, OK 73072 Phone: 405-217-9997 Fax: 405-307-8520 | |
Mishell J Kerr, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 317 E Himes St, Norman, OK 73069 Phone: 405-632-6688 | |
Jaime L Mcminn, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1215 Crossroads Blvd Ste 100, Norman, OK 73072 Phone: 405-310-2715 Fax: 405-310-6720 | |
Matthew J Jones, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 15951 Little Axe Dr, Norman, OK 73026 Phone: 405-447-0300 | |
Crystal Ann Conley, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2920 Adams Rd Ste 100a, Norman, OK 73069 Phone: 580-736-3557 Fax: 188-823-6307 | |
Megan Rachelle Day, ARNP-CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2342 N Interstate Dr, Norman, OK 73072 Phone: 405-310-3113 |